Androgen receptor as a target in androgen-independent prostate cancer (Q34149491)

31 July 2017

1 reference

title

Androgen receptor as a target in androgen-independent prostate cancer (English)

1 reference

31 July 2017

1 reference

Steven P Balk

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

issue

3 Suppl 1

1 reference

31 July 2017

page(s)

132-8; discussion 138-9

1 reference

The nuclear receptor superfamily: the second decade

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Androgen receptor defects: historical, clinical, and molecular perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Mechanisms of androgen receptor activation and function.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Bilateral orchiectomy with or without flutamide for metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Maximum androgen blockade in advanced prostate cancer: a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Bicalutamide for advanced prostate cancer: the natural versus treated history of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

High dose bicalutamide for androgen independent prostate cancer: effect of prior hormonal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Treatment of metastatic prostate cancer. Lessons from the androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

The development of androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Androgen receptors in endocrine-therapy-resistant human prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Androgen receptor expression in prostatic dysplasia (prostatic intraepithelial neoplasia) in the human prostate: an immunohistochemical and in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Expression of androgen receptor and growth factors in premalignant lesions of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Androgen receptor expression in prostatic intraepithelial neoplasia and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Domains of the Human Androgen Receptor Involved in Steroid Binding, Transcriptional Activation, and Subcellular Localization

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Androgen receptor gene mutations in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Nuclear receptor coregulators: cellular and molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Sequence and characterization of a coactivator for the steroid hormone receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

TRAM-1, A Novel 160-kDa Thyroid Hormone Receptor Activator Molecule, Exhibits Distinct Properties from Steroid Receptor Coactivator-1

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2).

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Estrogen receptor activation function 1 works by binding p160 coactivator proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Different expression of androgen receptor coactivators in human prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

A transcriptional co-repressor that interacts with nuclear hormone receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Molecular basis of agonism and antagonism in the oestrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Inhibition of androgen receptor-mediated transcription by amino-terminal enhancer of split

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

SRY interacts with and negatively regulates androgen receptor transcriptional activity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Multiple G1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Cyclin E as a coactivator of the androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Synergism between androgens and protein kinase-C on androgen-regulated gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Activation of the human androgen receptor through a protein kinase A signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Forskolin-Induced Dephosphorylation of the Androgen Receptor Impairs Ligand Binding

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

The pharmacokinetics of Casodex in prostate cancer patients after single and during multiple dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901593-5

7 January 2021

10.1016/S0090-4295(02)01593-5

Identifiers

DOI

1 reference

31 July 2017

1 reference